2022, Number 4
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2022; 20 (4)
Idiopathic chilblains. A case report
Zajdman FD, Armendáriz BY, Pérez CAE, Sáenz CCI, Toussaint CS, Vega MME
Language: Spanish
References: 17
Page: 415-419
PDF size: 245.42 Kb.
ABSTRACT
Perniosis or chilblains is an inflammatory skin disease caused by
an inadequate vascular response to cold temperature. It presents
as painful and pruritic erythro-violaceous lesions in acral
sites. It can be primary (idiopathic perniosis) or secondary to an
underlying disease such as connective tissue disorders, proliferative
blood cell line disorders, sars-cov-2 infection, among others.
The management of idiopathic perniosis consists of avoiding
exposure to cold, and topical steroids if needed. We present
a 59-year-old man, who presented with a three-month history
of pruritic and painful erythematous-violaceous lesions on the
palms and fingertips. The biopsy was compatible with perniosis,
and diseases related to secondary perniosis were ruled out.
Follow-up at four weeks showed complete resolution of lesions
with conservative measures and topical steroids.
REFERENCES
Corlett WT, Dermatitis hiemalis. A recurrent inflammation of theskin associated with cold weather, jama 1902; xxxxix(25):1583-8. Disponibleen: https://doi.org/10.1001/jama.1902.52480510023001e.
Nyssen A, Benhadou F, Magnée M, André J, Koopmansch C y WautrechtJ, Chilblains, Vasa 2020; 49(2):133-40. Disponible en: https://doi.org/10.1024/0301-1526/a000838.
Tobón MX y Rodríguez G, Eritema pernio: una enfermedad misteriosa,ces Medicina 2013; 27(1):113-26.
Zaladonis A, Huang S y Hsu S, covid toes or pernio?, Clin Dermatol2020; 38(6):764-7. Disponible en: https://doi.org/10.1016/j.clindermatol.2020.06.002.
Bielsa Marsol I, Perniosis, Semin Fund Esp Reumatol 2012; 13(2):55-61. Disponibleen: https://doi.org/10.1016/j.semreu.2011.12.003.
Külcü Çakmak S, Gönül M, Og˘uz ID, Yayla D, Gül Ü y Köse K, Demographical,laboratory and associated findings in patients with perniosis,J Eur Acad Dermatol Venereol 2014; 28(7):891-4. Disponible en: https://doi.org/10.1111/jdv.12199.
Cappel MA, Cappel JA y Wetter DA, Pernio (chilblains), sars-cov-2,and covid toes unified through cutaneous and systemic mechanisms,Mayo Clin Proc 2021; 96(4):989-1005. Disponible en: https://doi.org/10.1016/j.mayocp.2021.01.009.
Takci Z, Vahaboglu G y Eksioglu H, Epidemiological patterns ofperniosis, and its association with systemic disorder, Clin Exp Dermatol2012; 37(8):844-9. Disponible en: https://doi.org/10.1111/j.1365-2230.2012.04435.x.
Viguier M, Pinquier L, Cavelier-Balloy B, De la Salmonière P, CordolianiF, Flageul B et al., Clinical and histopathologic features and immunologicvariables in patients with severe chilblains: a study of therelationship to lupus erythematosus, Medicine 2001; 80(3):180-8. doi:
10.1097/00005792-200105000-00004.10. Guadagni M y Nazzari G, Acute perniosis in elderly people: a predictivesign of systemic disease?, Acta Derm Venereol 2010; 90(5):545-6.Disponible en: https://doi.org/10.2340/00015555-0918.
Molaee H, Emadi SN, M’Imunya JMN, Davoudi-Monfared E, MohammedA y Razavi Z, Chilblain or perniosis-like skin lesions in childrenduring the covid-19 pandemic: a systematic review of articles, DermatolTher 2022; 35(3):e15298. Disponible en: https://doi.org/10.1111/dth.15298.
Hubiche T, Cardot-Leccia N, Le Duff F, Seitz-Polski B, Giordana P, ChiaveriniC et al., Clinical, laboratory, and interferon-alpha response characteristicsof patients with chilblain-like lesions during the covid-19pandemic, jama Dermatol 2021; 157(2):202-6. Disponible en: https://doi.org/10.1001/jamadermatol.2020.4324.
Yang X, Pérez OA y English JC, Adult perniosis and cryoglobulinemia:a retrospective study and review of the literature, J Am AcadDermatol 2010; 62(6):e21-2. Disponible en: https://doi.org/10.1016/j.jaad.2009.10.030.
Cappel JA y Wetter D, Clinical characteristics, etiologic associations,laboratory findings, treatment, and proposal of diagnostic criteria ofpernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to2011, Mayo Clin Proc 2014; 89(2):207-15. Disponible en: https://doi.org/10.1016/j.mayocp.2013.09.020.
Boada A, Bielsa I, Fernández-Figueras MT y Ferrándiz C, Perniosis: clinicaland histopathological analysis, Am J of Dermatopathol 2010; 32(1):19-23. Disponible en: https://doi.org/10.1097/DAD.0b013e3181af1d24.
Cribier B, Djeridi N, Peltre B y Grosshans E, A histologic and immunohistochemicalstudy of chilblains, J Am Acad Dermatol 2001; 45(6):924-9. Disponible en: https://doi.org/10.1067/mjd.2001.117861.
Al-Sudany NK, Treatment of primary perniosis with oral pentoxifylline:a double-blind placebo-controlled randomized therapeutictrial, Dermatol Ther 2016; 29(4):263-8. Disponible en: https://doi.org/10.1111/dth.12350.